The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months-Reference-Cited by-同舟云学术

The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months

Published:2016-02-05 Issue:2 Volume:173 Page:260-264
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Lunning Matthew A.¹,Migliacci Jocelyn C.²,Hilden Patrick³,Devlin Sean M.³,Castro-Malaspina Hugo²⁴,Giralt Sergio²⁴,Perales Miguel-Angel²⁴,Zelenetz Andrew D.²⁴,Moskowitz Craig H.²⁴,Sauter Craig S.²⁴

Affiliation:

1. Department of Medicine; University of Nebraska; Omaha NE USA

2. Division of Hematologic Oncology; Department of Medicine; Memorial Sloan Kettering Cancer Center; New York NY USA

3. Department of Epidemiology and Biostatistics; Memorial Sloan Kettering Cancer Center; New York NY USA

4. Department of Medicine; Weill Cornell Medical College; New York NY USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13947/fullpdf

Reference15 articles.

2. Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National lymphocare study;Casulo;Journal of Clinical Oncology,2015

3. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group;Cheson;Journal of Clinical Oncology,1999

4. Revised response criteria for malignant lymphoma;Cheson;Journal of Clinical Oncology,2007

5. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project;Evens;Cancer,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation;Transplantation and Cellular Therapy;2024-09

2. Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

3. Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis;BMC Cancer;2023-01-23

4. Precision medicine in follicular lymphoma: Focus on predictive biomarkers;Hematological Oncology;2020-08-24

5. Follicular lymphoma: Update on management and emerging therapies at the dawn of the new decade;Hematological Oncology;2020-01-24